Sana Biotechnology Inc vs VNET Group Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while VNET Group Inc trades at $7.7 (market cap $2.19B). The key difference: VNET Group Inc is far larger — about 2.5× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| SANA | VNET | |
|---|---|---|
Market Cap | $873.84M | $2.19B |
Sector | Health | Technology |
52-Week High | $5.92 | $14.03 |
52-Week Low | $2.68 | $7.34 |
Enterprise Value | $848.03M | $5.32B |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →